GABA-B receptor modulators

Details for Australian Patent Application No. 2006327317 (hide)

Owner AstraZeneca AB

Inventors Brailsford, Wayne; Svensson, Tor; Gustafsson, Linda; Bauer, Udo

Agent Davies Collison Cave

Pub. Number AU-B-2006327317

PCT Pub. Number WO2007/073300

Priority 0502904-6 23.12.05 SE

Filing date 21 December 2006

Wipo publication date 28 June 2007

Acceptance publication date 25 November 2010

International Classifications

C07D 233/90 (2006.01) Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings

A61K 31/4164 (2006.01) - 1,3-Diazoles

A61P 1/04 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

C07D 233/88 (2006.01) Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 403/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 405/12 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 409/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

C07D 413/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

Event Publications

3 July 2008 PCT application entered the National Phase

  PCT publication WO2007/073300 Priority application(s): WO2007/073300

25 November 2010 Application Accepted

  Published as AU-B-2006327317

31 March 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under reg. 22.2I(2). This application has been accepted or advertised accepted. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006327320-Novel benzimidazole derivatives as vanilloid receptor 1 (VRL) inhibitors

2006327316-Imidazoles as GABA-B receptor modulators